Bridgewater Advisors Inc. Acquires 21,218 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Bridgewater Advisors Inc. increased its holdings in Aspen Aerogels, Inc. (NYSE:ASPNFree Report) by 37.8% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 77,357 shares of the construction company’s stock after purchasing an additional 21,218 shares during the period. Bridgewater Advisors Inc.’s holdings in Aspen Aerogels were worth $2,142,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of ASPN. Vanguard Group Inc. increased its holdings in Aspen Aerogels by 5.1% during the 1st quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock worth $63,707,000 after acquiring an additional 175,906 shares during the period. Hood River Capital Management LLC boosted its stake in Aspen Aerogels by 12.2% during the first quarter. Hood River Capital Management LLC now owns 3,300,443 shares of the construction company’s stock valued at $58,088,000 after buying an additional 357,895 shares during the period. Driehaus Capital Management LLC boosted its stake in Aspen Aerogels by 130.4% during the second quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock valued at $51,439,000 after buying an additional 1,220,724 shares during the period. Dimensional Fund Advisors LP grew its position in Aspen Aerogels by 21.3% during the second quarter. Dimensional Fund Advisors LP now owns 1,374,631 shares of the construction company’s stock worth $32,790,000 after buying an additional 240,921 shares in the last quarter. Finally, American Century Companies Inc. raised its holdings in shares of Aspen Aerogels by 562.3% in the 2nd quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock valued at $18,382,000 after acquiring an additional 654,350 shares in the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. StockNews.com raised Aspen Aerogels to a “sell” rating in a report on Thursday, October 31st. HC Wainwright restated a “buy” rating and set a $30.00 price objective on shares of Aspen Aerogels in a research report on Wednesday, October 16th. Piper Sandler cut their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. Benchmark restated a “buy” rating and set a $14.00 price target on shares of Aspen Aerogels in a research report on Thursday, August 8th. Finally, Barclays started coverage on Aspen Aerogels in a report on Tuesday, August 6th. They issued an “overweight” rating and a $27.00 price objective for the company. One research analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $29.40.

Read Our Latest Stock Report on ASPN

Insiders Place Their Bets

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the sale, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Donald R. Young sold 63,355 shares of the business’s stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the transaction, the chief executive officer now owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by company insiders.

Aspen Aerogels Stock Performance

NYSE:ASPN opened at $16.85 on Thursday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.82 and a current ratio of 3.46. Aspen Aerogels, Inc. has a fifty-two week low of $8.76 and a fifty-two week high of $33.15. The firm has a market cap of $1.30 billion, a PE ratio of -1,685.00 and a beta of 2.21. The business has a 50 day moving average price of $23.58 and a 200-day moving average price of $24.66.

Aspen Aerogels (NYSE:ASPNGet Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.16. Aspen Aerogels had a return on equity of 0.74% and a net margin of 0.39%. The company had revenue of $117.80 million during the quarter, compared to analyst estimates of $101.99 million. During the same quarter last year, the firm posted ($0.22) earnings per share. The firm’s revenue was up 144.4% on a year-over-year basis. Equities research analysts predict that Aspen Aerogels, Inc. will post 0.1 earnings per share for the current year.

Aspen Aerogels Company Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Further Reading

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPNFree Report).

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.